Primary PCI in AMI
|
|
|
|
Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus
Am J Cardiol (2008) 101; 596-601
X. Yang, W. Y. So, A. P. Kong, R. C. Ma, G. T. Ko, C. S. Ho, C. W. Lam, C. S. Cockram, J. C. Chan and P. C. Tong |
|
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice
Am J Cardiol (2008) 101; 919-24
R. T. Yan, A. T. Yan, C. B. Granger, J. Lopez-Sendon, D. Brieger, B. Kennelly, A. Budaj, P. G. Steg, A. A. Georgescu, Q. Hassan and S. G. Goodman |
|
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)
Am J Cardiol (2008) 101; 1716-22
B. P. Yan, S. J. Duffy, D. J. Clark, J. Lefkovits, R. Warren, R. Gurvitch, R. Lew, M. Sebastian, A. Brennan, N. Andrianopoulos, C. M. Reid and A. E. Ajani |
|
Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting
Am J Cardiol (2008) 101; 562-7
T. Yamaguchi, M. Terashima, T. Akasaka, T. Hayashi, K. Mizuno, T. Muramatsu, M. Nakamura, S. Nakamura, S. Saito, M. Takano, T. Takayama, J. Yoshikawa and T. Suzuki |
|
An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials
Am Heart J (2008) 156; 564-72, 72 e1-2
H. C. Wijeysundera, J. J. You, B. K. Nallamothu, H. M. Krumholz, W. J. Cantor and D. T. Ko |
|
Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents
Catheter Cardiovasc Interv (2008) 71; 594-8
C. Whan Lee, S. H. Kim, J. Suh, D. W. Park, S. H. Lee, Y. H. Kim, M. K. Hong, J. J. Kim, S. W. Park and S. J. Park |
|
Identifying the vulnerable patient with rupture-prone plaque
Am J Cardiol (2008) 101; 3F-10F
H. S. Weintraub |
|
Changes in unstable coronary atherosclerotic plaque composition after balloon angioplasty as determined by analysis of intravascular ultrasound radiofrequency
Am J Cardiol (2008) 101; 173-8
H. Wei, F. Schiele, V. Descotes-Genon, J. Oettinger, N. Meneveau, M. F. Seronde, F. Ecarnot, J. Varini and J. P. Bassand |
|
Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease
Am J Cardiol (2008) 101; 618-24
C. M. Webb, A. G. Elkington, M. M. Kraidly, N. Keenan, D. J. Pennell and P. Collins |
|
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review
Circulation (2008) 118; 1828-36
P. J. Vlaar, T. Svilaas, K. Damman, B. J. de Smet, J. G. Tijssen, H. L. Hillege and F. Zijlstra |
|
Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry)
Am J Cardiol (2008) 101; 947-52
L. Vignali, F. Saia, A. Manari, A. Santarelli, A. Rubboli, E. Varani, G. Piovaccari, A. Menozzi, G. Percoco, A. Benassi, G. Rusticali, P. Marzaroli, P. Guastaroba, R. Grilli, A. Maresta and A. Marzocchi |
|
Improving reperfusion in patients with myocardial infarction
N Engl J Med (2008) 358; 634-7
G. W. Vetrovec |
|
Impact on contrast, fluoroscopy, and catheter utilization from knowing the coronary artery bypass graft anatomy before diagnostic coronary angiography
Am J Cardiol (2008) 101; 1729-32
I. Varghese, D. M. Boatman, C. T. Peters, J. Daye, A. Haider, M. Roesle, S. Banerjee and E. S. Brilakis |
|
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
Lancet (2008) 372; 537-46
A. W. Van't Hof, J. Ten Berg, T. Heestermans, T. Dill, R. C. Funck, W. van Werkum, J. H. Dambrink, H. Suryapranata, G. van Houwelingen, J. P. Ottervanger, P. Stella, E. Giannitsis and C. Hamm |
|
Anatomic correlates of a normal perfusion scan using 64-slice computed tomographic coronary angiography
Am J Cardiol (2008) 101; 40-5
J. M. van Werkhoven, J. D. Schuijf, J. W. Jukema, L. J. Kroft, M. P. Stokkel, P. Dibbets-Schneider, G. Pundziute, A. J. Scholte, E. E. van der Wall and J. J. Bax |
|
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial
JAMA (2008) 299; 1788-99
M. Valgimigli, G. Campo, G. Percoco, L. Bolognese, C. Vassanelli, S. Colangelo, N. de Cesare, A. E. Rodriguez, M. Ferrario, R. Moreno, T. Piva, I. Sheiban, G. Pasquetto, F. Prati, M. S. Nazzaro, G. Parrinello and R. Ferrari |
|
Thrombus aspiration during primary percutaneous coronary intervention
N Engl J Med (2008) 358; 2639; author reply 40-1
B. F. Uretsky |
|
Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty
Am J Cardiol (2008) 101; 753-7
D. Tzivoni, D. Koukoui, V. Guetta, L. Novack and G. Cowing |
|
Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial)
Am J Cardiol (2008) 101; 1523-30
K. R. Tuttle, L. A. Shuler, D. P. Packard, J. E. Milton, K. B. Daratha, D. M. Bibus and R. A. Short |
|
Thrombus aspiration during primary percutaneous coronary intervention
N Engl J Med (2008) 358; 2640; author reply 40-1
H. Tomoda, N. Izumi and N. Aoki |
|
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction
Am J Cardiol (2008) 101; 286-92
H. H. Ting, M. T. Roe, B. J. Gersh, J. A. Spertus, J. S. Rumsfeld, F. S. Ou, J. Kao, K. H. Long, D. R. Holmes, Jr. and E. D. Peterson |
|
Usefulness of persistent symptoms of depression to predict physical health status 12 months after an acute coronary syndrome
Am J Cardiol (2008) 101; 15-9
B. D. Thombs, R. C. Ziegelstein, D. E. Stewart, S. E. Abbey, K. Parakh and S. L. Grace |
|
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial
Circulation (2008) 118; 49-57
H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, D. Kivelitz and G. Schuler |
|
Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time
Heart (2009) 95; 362-9
C. J. Terkelsen, E. H. Christiansen, J. T. Sorensen, S. D. Kristensen, J. F. Lassen, L. Thuesen, H. R. Andersen, W. Vach and T. T. Nielsen |
|
Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction
Am J Cardiol (2008) 101; 419-21
M. Terashima, S. Fujiwara, G. Y. Yaginuma, K. Takizawa, U. Kaneko and T. Meguro |
|
Primary PCI in ST-segment elevation myocardial infarction
N Engl J Med (2008) 358; 1752; author reply 52-3
J. W. Tam, K. M. Bhagirath and R. K. Philipp |
|
In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics
Am J Cardiol (2008) 101; 471-6
M. Takano, I. K. Jang, S. Inami, M. Yamamoto, D. Murakami, K. Okamatsu, K. Seimiya, T. Ohba and K. Mizuno |
|
Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease
Am J Cardiol (2008) 101; 1259-62
H. Takagi, N. Kawai and T. Umemoto |
|
Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients > or = 65 years of age
Am J Cardiol (2008) 101; 930-6
S. M. Tahir, L. L. Price, P. B. Shah and F. G. Welt |
|
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)
Am J Cardiol (2009) 103; 785-90
N. Taglieri, F. Saia, V. Guiducci, S. Tondi, F. Conrotto, C. Marrozzini, G. Rocchi, E. Biagini, M. L. Reggiani, P. Giacometti, G. Piovaccari, A. Manari and A. Marzocchi |
|
Effectiveness of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction from a 5-year single-center experience
Am J Cardiol (2008) 101; 162-8
S. Tadel-Kocjancic, S. Zorman, A. Jazbec, V. Gorjup, D. Zorman and M. Noc |
|
Primary percutaneous coronary intervention
N Engl J Med (2008) 358; 432; author reply 32-3
S. Szabo, T. Oikonomopoulos and H. M. Hoffmeister |
|
Thrombus aspiration during primary percutaneous coronary intervention
N Engl J Med (2008) 358; 557-67
T. Svilaas, P. J. Vlaar, I. C. van der Horst, G. F. Diercks, B. J. de Smet, A. F. van den Heuvel, R. L. Anthonio, G. A. Jessurun, E. S. Tan, A. J. Suurmeijer and F. Zijlstra |
|
Bivalirudin during primary PCI in acute myocardial infarction
N Engl J Med (2008) 358; 2218-30
G. W. Stone, B. Witzenbichler, G. Guagliumi, J. Z. Peruga, B. R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B. J. Gersh, S. J. Pocock, G. Dangas, S. C. Wong, A. J. Kirtane, H. Parise and R. Mehran |
|
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial
JAMA (2008) 299; 1903-13
G. W. Stone, M. Midei, W. Newman, M. Sanz, J. B. Hermiller, J. Williams, N. Farhat, K. W. Mahaffey, D. E. Cutlip, P. J. Fitzgerald, P. Sood, X. Su and A. J. Lansky |
|
Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention
Circulation (2008) 118; 538-51
G. W. Stone |
|
Aspiration of embolized thrombus during primary percutaneous coronary intervention
Catheter Cardiovasc Interv (2008)
M. G. Stoel, C. von Birgelen and F. Zijlstra |
|
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study
Catheter Cardiovasc Interv (2008) 71; 283-9
M. G. Stoel, K. M. Marques, C. C. de Cock, J. G. Bronzwaer, C. von Birgelen and F. Zijlstra |
|
Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly
Eur Heart J (2008) 29; 2953-4
P. G. Steg and G. Ducrocq |
|
Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes
Circulation (2009) 119; 1311-9
M. Srinivasan, C. Rihal, D. R. Holmes and A. Prasad |
|
Surgery, not percutaneous revascularization, is the preferred strategy for patients with significant left main coronary stenosis
Circulation (2009) 119; 1013-20
C. R. Smith |
|
Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction
Am J Cardiol (2008) 101; 446-51
J. J. Smit, J. P. Ottervanger, R. J. Slingerland, J. J. Kolkman, H. Suryapranata, J. C. Hoorntje, J. H. Dambrink, A. T. Gosselink, M. J. de Boer, F. Zijlstra and A. W. van 't Hof |
|
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease
Am J Cardiol (2008) 101; 1741-6
M. H. Shishehbor, L. P. Oliveira, M. S. Lauer, D. L. Sprecher, K. Wolski, L. Cho, B. J. Hoogwerf and S. L. Hazen |
|
Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy
J Am Coll Cardiol (2008) 52; 1015-21
A. Sharp, R. Tapp, D. P. Francis, G. T. S. A. Mc, A. D. Hughes, A. V. Stanton, A. Zambanini, N. Chaturvedi, S. Byrd, N. R. Poulter, P. S. Sever and J. Mayet |
|
Outcomes and quality of life in patients>or=85 years of age with ST-elevation myocardial infarction
Am J Cardiol (2009) 103; 170-4
P. Shah, A. H. Najafi, J. A. Panza and H. A. Cooper |
|
Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age
Am J Cardiol (2008) 101; 1531-6
S. Setoguchi, D. H. Solomon, R. Levin and W. C. Winkelmayer |
|
Outcome after primary percutaneous intervention in acute myocardial infarction: role of microcirculatory perfusion -- a crucial piece in the puzzle
Eur Heart J (2009) 30; 530-1
R. Senior |
|
Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients with acute ST-elevation myocardial infarction
Am J Cardiol (2008) 101; 46-52
K. H. Scholz, R. Hilgers, D. Ahlersmann, H. Duwald, R. Nitsche, G. von Knobelsdorff, B. Volger, K. Moller and F. K. Keating |
|
Assessment of changes in non-calcified atherosclerotic plaque volume in the left main and left anterior descending coronary arteries over time by 64-slice computed tomography
Am J Cardiol (2008) 101; 579-84
M. Schmid, S. Achenbach, D. Ropers, S. Komatsu, U. Ropers, W. G. Daniel and T. Pflederer |
|
The effect of thrombectomy on myocardial blush in primary angioplasty: the Randomized Evaluation of Thrombus Aspiration by two thrombectomy devices in acute Myocardial Infarction (RETAMI) trial
Catheter Cardiovasc Interv (2008) 71; 84-91
G. Sardella, M. Mancone, B. L. Nguyen, L. De Luca, A. Di Roma, R. Colantonio, A. Petrolini, G. Conti and F. Fedele |
|
Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial
J Am Coll Cardiol (2009) 53; 309-15
G. Sardella, M. Mancone, C. Bucciarelli-Ducci, L. Agati, R. Scardala, I. Carbone, M. Francone, A. Di Roma, G. Benedetti, G. Conti and F. Fedele |
|
Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
Am J Cardiol (2008) 101; 293-9
P. Roy, A. N. Buch, A. Javaid, T. Okabe, V. Raya, T. L. Pinto Slottow, D. H. Steinberg, K. Smith, Z. Xue, N. Gevorkian, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, J. Lindsay and R. Waksman |
|
Usefulness of cardiac magnetic resonance imaging combined with low-dose dobutamine stress to detect an abnormal ventricular stress response in children and young adults after fontan operation at young age
Am J Cardiol (2008) 101; 1657-62
D. Robbers-Visser, D. Jan Ten Harkel, L. Kapusta, J. L. Strengers, M. Dalinghaus, F. J. Meijboom, P. M. Pattynama, A. J. Bogers and W. A. Helbing |
|
Platelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease
Am J Cardiol (2008) 101; 1359-63
R. Qayyum, D. M. Becker, L. R. Yanek, T. F. Moy, L. C. Becker, N. Faraday and D. Vaidya |
|
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
Am J Cardiol (2008) 101; 63-8
T. Pucelikova, R. Mehran, A. J. Kirtane, Y. H. Kim, M. Fahy, G. Weisz, A. J. Lansky, I. Moussa, W. A. Gray, M. B. Collins, S. K. Kodali, G. W. Stone, J. W. Moses, M. B. Leon and G. Dangas |
|
Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis
Catheter Cardiovasc Interv (2009) 73; 301-7
S. B. Prasad, R. Whitbourn, Y. Malaiapan, W. Ahmar, A. MacIsaac and I. T. Meredith |
|
Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus
Am Heart J (2008) 155; 284-9
A. Porter, A. R. Assali, A. Zahalka, Z. Iakobishvili, D. Brosh, E. I. Lev, A. Mager, A. Battler, R. Kornowski and D. Hasdai |
|
Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry)
Am J Cardiol (2008) 101; 953-9
D. Planer, R. Beyar, Y. Almagor, S. Banai, V. Guetta, H. Miller, R. Kornowski, S. Brandes, R. Krakover, M. Solomon and C. Lotan |
|
Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study)
Am J Cardiol (2008) 101; 303-7
D. S. Pinto, A. J. Kirtane, Y. B. Pride, S. A. Murphy, M. S. Sabatine, C. P. Cannon and C. M. Gibson |
|
Head to head comparison between perfusion and function during accelerated high-dose dipyridamole magnetic resonance stress for the detection of coronary artery disease
Am J Cardiol (2008) 101; 8-14
A. Pingitore, M. Lombardi, B. Scattini, D. De Marchi, G. D. Aquaro, V. Positano and E. Picano |
|
Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging
Am J Cardiol (2008) 101; 1408-12
G. Pilz, A. Jeske, M. Klos, E. Ali, B. Hoefling, R. Scheck and P. Bernhardt |
|
Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases
Am Heart J (2008) 155; 42-8
L. Pilote, C. A. Beck, M. J. Eisenberg, K. Humphries, L. Joseph, J. R. Penrod and J. V. Tu |
|
Outcome in transferred and nontransferred patients after primary percutaneous coronary intervention for ischaemic out-of-hospital cardiac arrest
Catheter Cardiovasc Interv (2008) 71; 147-51
H. O. Peels, G. A. Jessurun, I. C. van der Horst, A. E. Arnold, L. H. Piers and F. Zijlstra |
|
Disparities in use of same-day percutaneous coronary intervention for patients with ST-elevation myocardial infarction in Florida, 2001-2005
Am J Cardiol (2008) 102; 802-8
E. B. Pathak and J. A. Strom |
|
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study)
Am J Cardiol (2009) 103; 181-6
M. R. Patel, M. E. Pfisterer, A. Betriu, P. Widmisky, D. R. Holmes, Jr., W. W. O'Neill, A. Stebbins, F. Van de Werf, P. W. Armstrong and C. B. Granger |
|
Current status of percutaneous coronary intervention with drug-eluting stents in Asia
Circulation (2008) 118; 2730-7
S. J. Park and Y. H. Kim |
|
Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease
Circulation (2008) 117; 2079-86
D. W. Park, S. C. Yun, S. W. Lee, Y. H. Kim, C. W. Lee, M. K. Hong, J. J. Kim, S. J. Choo, H. Song, C. H. Chung, J. W. Lee, S. W. Park and S. J. Park |
|
Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a key process analysis of patient and program factors
Am Heart J (2008) 155; 290-7
S. V. Parikh, J. A. Jacobi, E. Chu, T. A. Addo, J. J. Warner, K. A. Delaney, D. K. McGuire, J. A. deLemos, J. E. Cigarroa, S. A. Murphy and E. C. Keeley |
|
Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome
Am J Cardiol (2008) 101; 1-7
H. Otake, J. Shite, T. Shinke, S. Watanabe, Y. Tanino, D. Ogasawara, T. Sawada, K. Hirata and M. Yokoyama |
|
Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention
Am J Cardiol (2008) 101; 780-5
M. D. Osten, J. Ivanov, J. Eichhofer, P. H. Seidelin, J. R. Ross, A. Barolet, E. M. Horlick, D. Ing, L. Schwartz, K. Mackie and V. Dzavik |
|
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Eur Heart J (2009)
S. Orn, C. Manhenke, T. Ueland, J. K. Damas, T. E. Mollnes, T. Edvardsen, P. Aukrust and K. Dickstein |
|
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis
JAMA (2008) 300; 71-80
M. O'Donoghue, W. E. Boden, E. Braunwald, C. P. Cannon, T. C. Clayton, R. J. de Winter, K. A. Fox, B. Lagerqvist, P. A. McCullough, S. A. Murphy, R. Spacek, E. Swahn, L. Wallentin, F. Windhausen and M. S. Sabatine |
|
Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction
Am J Cardiol (2008) 101; 747-52
J. Nunez, E. Nunez, V. Bodi, J. Sanchis, G. Minana, L. Mainar, E. Santas, P. Merlos, E. Rumiz, H. Darmofal, A. M. Heatta and A. Llacer |
|
Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction
Am Heart J (2008) 155; 673-9
M. B. Nienhuis, J. P. Ottervanger, M. J. de Boer, J. H. Dambrink, J. C. Hoorntje, A. T. Gosselink, H. Suryapranata and A. W. van't Hof |
|
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention
Eur Heart J (2008) 29; 1843-50
G. Niccoli, S. Giubilato, E. Russo, C. Spaziani, A. Leo, I. Porto, A. M. Leone, F. Burzotta, S. Riondino, F. Pulcinelli, L. M. Biasucci and F. Crea |
|
Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms
JAMA (2009) 301; 487-8
G. Ndrepepa, A. Kastrati, J. Mehilli, D. Antoniucci and A. Schomig |
|
Impact of intramural thrombus in coronary arteries on the accuracy of tissue characterization by in vivo intravascular ultrasound radiofrequency data analysis
Am J Cardiol (2008) 101; 1079-83
K. Nasu, E. Tsuchikane, O. Katoh, D. G. Vince, P. M. Margolis, R. Virmani, J. F. Surmely, M. Ehara, Y. Kinoshita, H. Fujita, M. Kimura, K. Asakura, Y. Asakura, T. Matsubara, M. Terashima and T. Suzuki |
|
Effectiveness of drug-eluting stents in real-world patients
JAMA (2008) 299; 454-5
D. Mukherjee and D. J. Moliterno |
|
Antithrombotic therapy to support primary PCI
N Engl J Med (2008) 358; 2280-2
D. A. Morrow |
|
Thrombus aspiration during primary percutaneous coronary intervention
N Engl J Med (2008) 358; 2639-40; author reply 40-1
F. P. Mongeon, M. J. Eisenberg and S. Rinfret |
|
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome
Am J Cardiol (2008) 101; 573-8
E. Missel, G. S. Mintz, S. G. Carlier, K. Sano, J. Qian, R. K. Kaple, C. Castellanos, G. Dangas, R. Mehran, J. W. Moses, G. W. Stone and M. B. Leon |
|
Abciximab in Patients With Acute ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading. A Randomized Double-Blind Trial
Circulation (2009)
J. Mehilli, A. Kastrati, S. Schulz, S. Frungel, S. G. Nekolla, W. Moshage, F. Dotzer, K. Huber, J. Pache, J. Dirschinger, M. Seyfarth, S. Martinoff, M. Schwaiger and A. Schomig |
|
Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial
Eur Heart J (2008) 29; 2972-80
A. Marzocchi, A. Manari, G. Piovaccari, C. Marrozzini, S. Marra, P. Magnavacchi, P. Sangiorgio, L. Marinucci, N. Taglieri, G. Gordini, N. Binetti, V. Guiducci, N. Franco, M. L. Reggiani and F. Saia |
|
Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study)
Am J Cardiol (2008) 101; 1560-6
A. Maresta, E. Varani, M. Balducelli, F. Varbella, C. Lettieri, L. Uguccioni, P. Sangiorgio and G. B. Zoccai |
|
Usefulness of 64-detector row computed tomography for evaluation of intracoronary stents in symptomatic patients with suspected in-stent restenosis
Am J Cardiol (2008) 101; 1567-73
N. Manghat, R. Van Lingen, P. Hewson, F. Syed, N. Kakani, I. Cox, C. Roobottom and G. Morgan-Hughes |
|
Effect of percutaneous coronary intervention on coronary blood flow at rest in myocardial sites remote from the intervention site in patients with stable angina pectoris
Am J Cardiol (2008) 101; 776-9
O. Manfrini, M. Slucca, C. Pizzi, A. Colombo, M. Viecca and R. Bugiardini |
|
Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents
JAMA (2008) 299; 2868-76
D. J. Malenka, A. V. Kaplan, F. L. Lucas, S. M. Sharp and J. S. Skinner |
|
Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
Eur Heart J (2009) 30; 757-64
M. Majidi, A. S. Kosinski, S. M. Al-Khatib, M. E. Lemmert, L. Smolders, A. van Weert, J. H. Reiber, D. Tzivoni, F. W. Bar, H. J. Wellens, A. P. Gorgels and M. W. Krucoff |
|
Effect of thrombus aspiration on infarct size and left ventricular function in high-risk patients with acute myocardial infarction treated by percutaneous coronary intervention. Results of a prospective controlled pilot study
Am Heart J (2009) 157; 583 e1-7
J. Lipiecki, S. Monzy, N. Durel, F. Cachin, P. Chabrot, A. Muliez, D. Morand, J. Maublant and J. Ponsonnaille |
|
Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention
Am J Cardiol (2008) 102; 6-11
E. I. Lev, R. Kornowski, H. Vaknin-Assa, A. Porter, I. Teplitsky, I. Ben-Dor, D. Brosh, S. Fuchs, A. Battler and A. Assali |
|
Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction
Am J Cardiol (2008) 101; 435-9
E. I. Lev, R. Kornowski, H. Vaknin-Assa, D. Brosh, S. Fuchs, A. Battler and A. Assali |
|
Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Am J Cardiol (2009) 103; 165-9
E. I. Lev, R. Kornowski, H. Vaknin-Assa, I. Ben-Dor, D. Brosh, I. Teplitsky, S. Fuchs, A. Battler and A. Assali |
|
Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome
Am Heart J (2009) 157; 569-75 e1
C. Lettieri, S. Savonitto, S. De Servi, G. Guagliumi, G. Belli, A. Repetto, E. Piccaluga, A. Politi, F. Ettori, B. Castiglioni, F. Fabbiocchi, N. De Cesare, G. Sangiorgi, G. Musumeci, M. Onofri, M. D'Urbano, S. Pirelli, R. Zanini and S. Klugmann |
|
A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus
J Am Coll Cardiol (2008) 52; 727-33
S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, K. S. Rhee, J. K. Chae, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, J. O. Jeong, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun, H. S. Kim and S. J. Park |
|
Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)
J Am Coll Cardiol (2008) 51; 1181-7
S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, H. S. Kim, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun and S. J. Park |
|
A citywide protocol for primary PCI in ST-segment elevation myocardial infarction
N Engl J Med (2008) 358; 231-40
M. R. Le May, D. Y. So, R. Dionne, C. A. Glover, M. P. Froeschl, G. A. Wells, R. F. Davies, H. L. Sherrard, J. Maloney, J. F. Marquis, E. R. O'Brien, J. Trickett, P. Poirier, S. C. Ryan, A. Ha, P. G. Joseph and M. Labinaz |
|
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction
Circulation (2008) 118; 1011-20
R. Y. Kwong, H. Sattar, H. Wu, G. Vorobiof, V. Gandla, K. Steel, S. Siu and K. A. Brown |
|
External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention
Heart (2008) 94; 1012-8
B. Kunadian, J. Dunning, R. Das, A. P. Roberts, R. Morley, A. J. Turley, D. Twomey, J. A. Hall, R. A. Wright, A. G. Sutton, D. F. Muir and M. A. de Belder |
|
Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention
Circulation (2008) 118; 1810-6
M. C. Kramer, A. C. van der Wal, K. T. Koch, J. P. Ploegmakers, R. J. van der Schaaf, J. P. Henriques, J. Baan, Jr., S. Z. Rittersma, M. M. Vis, J. J. Piek, J. G. Tijssen and R. J. de Winter |
|
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk
Circulation (2008) 117; 1018-27
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, L. Xiao, P. G. Jones, S. Fiske, F. A. Masoudi, S. P. Marso and J. A. Spertus |
|
Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial)
Am J Cardiol (2008) 101; 796-800
A. S. Kini, M. C. Kim, P. R. Moreno, P. Krishnan, O. C. Ivan and S. K. Sharma |
|
Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus
Am J Cardiol (2008) 101; 1263-8
M. Kimura, G. S. Mintz, N. J. Weissman, K. D. Dawkins, E. Grube, S. G. Ellis, L. A. Cannon, Z. Masud, L. Mandinov, D. Baim and G. W. Stone |
|
Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II)
Am J Cardiol (2008) 101; 1550-9
A. A. Khattab, J. Daemen, G. Richardt, P. Rioux, F. W. Amann, R. Levy, I. G. Horvath, R. C. Teles, F. Ordoubadi, M. Pieters, K. Wittebols, H. P. Stoll and P. W. Serruys |
|
A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction
Am J Cardiol (2008) 101; 790-5
D. M. Kent, R. Ruthazer, J. L. Griffith, J. R. Beshansky, T. W. Concannon, T. Aversano, C. L. Grines, R. J. Zalenski and H. P. Selker |
|
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial
J Am Coll Cardiol (2008) 51; 899-905
H. Kelbaek, C. J. Terkelsen, S. Helqvist, J. F. Lassen, P. Clemmensen, L. Klovgaard, A. Kaltoft, T. Engstrom, H. E. Botker, K. Saunamaki, L. R. Krusell, E. Jorgensen, H. H. Hansen, E. H. Christiansen, J. Ravkilde, L. Kober, K. F. Kofoed and L. Thuesen |
|
Primary percutaneous coronary intervention
N Engl J Med (2008) 358; 431; author reply 32-3
R. Kapoor and J. R. Kapoor |
|
Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study
J Am Coll Cardiol (2009) 53; 1101-9
Y. H. Jeong, S. W. Lee, B. R. Choi, I. S. Kim, M. K. Seo, C. H. Kwak, J. Y. Hwang and S. W. Park |
|
Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus
Am J Cardiol (2008) 101; 590-5
L. O. Jensen, P. Thayssen, G. S. Mintz, R. Egede, M. Maeng, A. Junker, A. Galloee, E. H. Christiansen, K. E. Pedersen, H. S. Hansen and K. N. Hansen |
|
Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics
Am J Cardiol (2008) 101; 452-6
A. Javaid, N. H. Siddiqi, D. H. Steinberg, A. N. Buch, T. L. Slottow, P. Roy, S. Sammee, T. Okabe, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, K. Smith, Z. Xue, J. Lindsay, Jr. and R. Waksman |
|
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)
Am Heart J (2008) 155; 113 e1-8
I. K. Jang, N. J. Weissman, M. H. Picard, M. R. Zile, V. Pettigrew, S. Shen, J. Tatsuno, M. G. Hibberd, D. Tzivoni and F. J. Wackers |
|
Cardiovascular outcomes after a change in prescription policy for clopidogrel
N Engl J Med (2008) 359; 1802-10
C. A. Jackevicius, J. V. Tu, V. Demers, M. Melo, J. Cox, S. Rinfret, D. Kalavrouziotis, H. Johansen, H. Behlouli, A. Newman and L. Pilote |
|
Late target lesion revascularization after implantation of sirolimus-eluting stent
Catheter Cardiovasc Interv (2008) 71; 299-303
M. K. Hong, G. S. Mintz, C. W. Lee, D. W. Park, S. W. Lee, Y. H. Kim, I. H. Jung, S. H. Kim, S. S. Cheong, J. J. Kim, S. W. Park and S. J. Park |
|
A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris
Am J Cardiol (2008) 101; 568-72
M. K. Hong, G. S. Mintz, C. W. Lee, J. W. Lee, J. H. Park, D. W. Park, S. W. Lee, Y. H. Kim, S. S. Cheong, J. J. Kim, S. W. Park and S. J. Park |
|
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
JAMA (2008) 299; 532-9
P. M. Ho, E. D. Peterson, L. Wang, D. J. Magid, S. D. Fihn, G. C. Larsen, R. A. Jesse and J. S. Rumsfeld |
|
Relation of a coronary artery calcium score higher than 400 to coronary stenoses detected using multidetector computed tomography and to traditional cardiovascular risk factors
Am J Cardiol (2008) 101; 1444-7
J. S. Ho, S. J. Fitzgerald, L. L. Stolfus, W. A. Wade, D. B. Reinhardt, C. E. Barlow and J. J. Cannaday |
|
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial
Catheter Cardiovasc Interv (2008) 71; 273-81
A. Hirsch, R. Nijveldt, P. A. van der Vleuten, R. A. Tio, W. J. van der Giessen, K. M. Marques, P. A. Doevendans, J. Waltenberger, J. M. Ten Berg, W. R. Aengevaeren, B. J. Biemond, J. G. Tijssen, A. C. van Rossum, J. J. Piek and F. Zijlstra |
|
Comparison of multislice computed tomography to gated single-photon emission computed tomography for imaging of healed myocardial infarcts
Am J Cardiol (2008) 101; 144-8
M. M. Henneman, J. D. Schuijf, P. Dibbets-Schneider, M. P. Stokkel, R. J. van der Geest, E. E. van der Wall and J. J. Bax |
|
Usefulness of 64-detector computed tomographic angiography for diagnosing in-stent restenosis in native coronary arteries
Am J Cardiol (2008) 101; 820-4
H. S. Hecht, M. Zaric, V. Jelnin, L. Lubarsky, M. Prakash and G. Roubin |
|
Time to take myocardial reperfusion injury seriously
N Engl J Med (2008) 359; 518-20
D. J. Hausenloy and D. M. Yellon |
|
Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention
Am J Cardiol (2009) 103; 779-84
A. K. Hassan, S. C. Bergheanu, H. Hasan-Ali, S. S. Liem, A. van der Laarse, R. Wolterbeek, D. E. Atsma, M. J. Schalij and J. W. Jukema |
|
Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation
Am J Cardiol (2008) 102; 1163-9
J. Y. Hahn, Y. B. Song, H. C. Gwon, Y. H. Choe, J. H. Kim, J. Sung, S. H. Choi, J. H. Choi, D. K. Kim, K. P. Hong, J. E. Park and S. H. Lee |
|
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary interventio
J Am Coll Cardiol (2008) 51; 529-35
n H. S. Gurm, D. E. Smith, J. S. Collins, D. Share, A. Riba, A. J. Carter, T. LaLonde, E. Kline-Rogers, M. O'Donnell, H. Changezi, M. Zughaib, R. Safian and M. Moscucci |
|
Primary percutaneous coronary intervention
N Engl J Med (2008) 358; 431-2; author reply 32-3
V. Gurewich |
|
Primary PCI in ST-segment elevation myocardial infarction
N Engl J Med (2008) 358; 1751-2; author reply 52-3
S. W. Glickman, K. A. Schulman and C. B. Cairns |
|
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy
Am J Cardiol (2008) 101; 1232-8
C. M. Gibson, Y. B. Pride, J. L. Buros, V. Kunadian, M. C. Southard, C. J. Harrigan, L. N. Ciaglo, M. S. Sabatine, C. P. Cannon and E. Braunwald |
|
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial
JAMA (2008) 299; 409-16
A. M. Galloe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P. R. Hansen, N. Bligaard, K. Saunamaki, A. Junker, J. Aaroe, U. Abildgaard, J. Ravkilde, T. Engstrom, J. S. Jensen, H. R. Andersen, H. E. Botker, S. Galatius, S. D. Kristensen, J. K. Madsen, L. R. Krusell, S. Z. Abildstrom, G. B. Stephansen and J. F. Lassen |
|
Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study
Eur Heart J (2009) 30; 566-75
S. Funaro, G. La Torre, M. Madonna, L. Galiuto, A. Scara, A. Labbadia, E. Canali, A. Mattatelli, F. Fedele, F. Alessandrini, F. Crea and L. Agati |
|
Angina pectoris and atherosclerotic risk factors in the multisite cardiac lifestyle intervention program
Am J Cardiol (2008) 101; 911-8
J. Frattaroli, G. Weidner, T. A. Merritt-Worden, S. Frenda and D. Ornish |
|
Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy
Am Heart J (2008) 156; 391-6
E. L. Fosbol, J. J. Thune, H. Kelbaek, H. R. Andersen, K. Saunamaki, T. T. Nielsen, L. S. Mortensen and L. Kober |
|
Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction
Catheter Cardiovasc Interv (2009) 73; 627-34
M. L. Fokkema, P. A. van der Vleuten, P. J. Vlaar, T. Svilaas and F. Zijlstra |
|
Patterns of use and effectiveness of early invasive strategy in non-ST-segment elevation acute coronary syndromes: an assessment by propensity score
Am Heart J (2008) 156; 946-53, 53 e2
I. Ferreira-Gonzalez, G. Permanyer-Miralda, M. Heras, J. Cunat, E. Civeira, F. Aros, J. J. Rodriguez, P. L. Sanchez, J. R. Marsal, A. Ribera, J. Marrugat and H. Bueno |
|
Potential impact of noncontrast computed tomography as gatekeeper for myocardial perfusion positron emission tomography in patients admitted to the chest pain unit
Am J Cardiol (2008) 101; 149-52
F. P. Esteves, R. Sanyal, C. A. Santana, L. Shaw and P. Raggi |
|
Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results of coronary artery bypass grafting
Am J Cardiol (2008) 101; 75-81
C. Dubois, J. Dens, P. Sinnaeve, A. Belmans, J. Van Cleemput, M. Mendez, J. Piessens and W. Desmet |
|
Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock
Am J Cardiol (2008) 101; 1537-40
A. Dominguez-Rodriguez, S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez and J. C. Kaski |
|
Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community
Circulation (2009) 119; 1101-7
R. Dhingra, M. J. Pencina, P. Schrader, T. J. Wang, D. Levy, K. Pencina, D. A. Siwik, W. S. Colucci, E. J. Benjamin and R. S. Vasan |
|
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials
Eur Heart J (2008) 29; 3002-10
G. De Luca, D. Dudek, G. Sardella, P. Marino, B. Chevalier and F. Zijlstra |
|
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)
Am Heart J (2008) 155; 1090-6
G. Dangas, G. W. Stone, M. D. Weinberg, J. Webb, D. A. Cox, B. R. Brodie, M. W. Krucoff, R. J. Gibbons, A. J. Lansky and R. Mehran |
|
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI)
Circulation (2008) 118; 268-76
N. Danchin, P. Coste, J. Ferrieres, P. G. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, P. Sans, B. Charbonnier, H. Eltchaninoff, P. Gueret, K. Khalife, P. Asseman, J. Puel, P. Goldstein, J. P. Cambou and T. Simon |
|
Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry
Am J Cardiol (2008) 101; 1105-11
J. Daemen, N. Kukreja, P. H. van Twisk, Y. Onuma, P. P. de Jaegere, R. van Domburg and P. W. Serruys |
|
Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris
Am J Cardiol (2008) 101; 1700-3
T. Cuisset, M. Hamilos, J. Sarma, G. Sarno, E. Wyffels, M. Vanderheyden, E. Barbato, J. Bartunek, B. De Bruyne and W. Wijns |
|
Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up
Am Heart J (2008) 155; 128-32
M. Co, E. Tay, C. H. Lee, K. K. Poh, A. Low, J. Lim, I. H. Lim, Y. T. Lim and H. C. Tan |
|
In vivo comparative study of linear versus geometrically correct three-dimensional reconstruction of coronary arteries
Am J Cardiol (2008) 101; 263-7
Y. S. Chatzizisis, G. D. Giannoglou, G. Sianos, A. Ziakas, D. Tsikaderis, P. Dardas, A. Matakos, C. Basdekidou, G. Misirli, C. Zamboulis, G. E. Louridas and G. E. Parcharidis |
|
Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)
Heart (2008) 94; 1019-25
A. J. Chase, E. B. Fretz, W. P. Warburton, W. P. Klinke, R. G. Carere, D. Pi, B. Berry and J. D. Hilton |
|
Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry
J Am Coll Cardiol (2008) 51; 2442-3
A. Chakrabarti, H. M. Krumholz, Y. Wang, J. S. Rumsfeld and B. K. Nallamothu |
|
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up
Eur Heart J (2008) 29; 1259-66
M. Busk, M. Maeng, K. Rasmussen, H. Kelbaek, P. Thayssen, U. Abildgaard, E. Vigholt, L. S. Mortensen, L. Thuesen, S. D. Kristensen, T. T. Nielsen and H. R. Andersen |
|
Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h
Eur Heart J (2009)
M. Busk, A. Kaltoft, S. S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H. E. Botker, J. F. Lassen, E. H. Christiansen, L. R. Krusell, H. R. Andersen, T. T. Nielsen and S. D. Kristensen |
|
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Circulation (2008) 118; 1335-46
C. E. Buller, Y. Fu, K. W. Mahaffey, T. G. Todaro, P. Adams, C. M. Westerhout, H. D. White, A. W. van 't Hof, F. J. Van de Werf, G. S. Wagner, C. B. Granger and P. W. Armstrong |
|
What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?
Catheter Cardiovasc Interv (2008) 71; 816-21
B. R. Brodie |
|
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study
Eur Heart J (2008) 29; 1127-35
S. J. Brener, D. J. Moliterno, P. E. Aylward, A. W. van't Hof, W. Ruzyllo, W. W. O'Neill, C. W. Hamm, C. M. Westerhout, C. B. Granger and P. W. Armstrong |
|
Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients
Am J Cardiol (2008) 101; 169-72
S. J. Brener, J. M. Galla, R. Bryant, 3rd, J. F. Sabik, 3rd and S. G. Ellis |
|
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock
Am J Cardiol (2008) 102; 287-91
L. Bonello, A. De Labriolle, P. Roy, D. H. Steinberg, T. L. Pinto Slottow, Z. Xue, K. Smith, R. Torguson, W. O. Suddath, L. F. Satler, K. M. Kent, A. D. Pichard and R. Waksman |
|
Primary PCI in ST-segment elevation myocardial infarction
N Engl J Med (2008) 358; 1751; author reply 52-3
P. Bogaty and J. M. Brophy |
|
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
Circulation (2008) 117; 886-96
E. Bates, C. Bode, M. Costa, C. M. Gibson, C. Granger, C. Green, K. Grimes, R. Harrington, K. Huber, N. Kleiman, D. Mochly-Rosen, M. Roe, Z. Sadowski, S. Solomon and P. Widimsky |
|
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial
J Am Coll Cardiol (2009) 53; 720-9
D. Atar, P. Petzelbauer, J. Schwitter, K. Huber, B. Rensing, J. D. Kasprzak, C. Butter, L. Grip, P. R. Hansen, T. Suselbeck, P. M. Clemmensen, M. Marin-Galiano, B. Geudelin and P. T. Buser |
|
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment
Am J Cardiol (2008) 101; 440-5
D. J. Angiolillo, M. A. Costa, S. B. Shoemaker, B. Desai, E. Bernardo, Y. Suzuki, R. K. Charlton, M. M. Zenni, L. A. Guzman and T. A. Bass |
|
Thrombus aspiration during primary percutaneous coronary intervention
N Engl J Med (2008) 358; 2640; author reply 40-1
J. L. Amato, Jr., F. E. Shamoon and J. I. Haft |
|
Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention
Am J Cardiol (2008) 101; 1413-7
A. Aggarwal, D. Dai, J. S. Rumsfeld, L. W. Klein and M. T. Roe |
|
|
|
|
|
|
|